Are you sure you want to log out?
You can always login again from the home screen

Thank You

Thank you for your feedback

COVID-19

COVID-19

A case of COVID-19 in the ICU presented by Prof. George Dimopoulos

COVID-19

Treatment and associated fungal Co-infection risk presented by Prof. Martin Heonigl

COVID-19

A case of fever, dyspnea, malaise and cough presented by Prof. Stefano Aliberti

COVID-19

COVID-19 a 2020 challenge

Webcast

COVID-19

COVID-19 treatment guidelines

Webcast

COVID-19

Remdesivir's Role in managing COVID-19

Webcast

COVID-19

SARS-CoV2 Variants: What do we know?

Webcast

COVID-19

MECO 2022

Webcast

COVID-19

MECO 2021

Webcast

COVID-19

Remdesivir approved for COVID-19 treatment- A review

COVID-19

Is GS-5245- an oral pro-drug of the parent nucleoside of remdesivir, safe for use in healthy people?

COVID-19

Real-world evidence on the effect of Remdesivir on mortality rate in hospitalized COVID-19 patients: Study

COVID-19

How effective and safe is remdesivir in patients hospitalized for COVID-19 with moderately and severely reduced kidney function?

COVID-19

Novel study investigates characteristics of hospitalized immunocompromised COVID-19

COVID-19

Irrespective of strain, COVID-19 patients in ICU treated with remdesivir had reduced readmission risk - Study

COVID-19

In hospitalised COVID-19 patients requiring high-flow oxygen in the US, Remdesivir is associated with reduced mortality

COVID-19

Lower mortality observed in cancer patients hospitalized for COVID-19 put on Remdesivir

COVID-19

Reduction in readmissions observed after Remdesivir treatment in immunocompromised patients hospitalised with COVID-19

COVID-19

Breathlessness found to be most common long COVID symptom in immunocompromised COVID-19 patients

COVID-19

Improvement in biomarkers associated with disease severity discovered in COVID-19 patients treated with Remdesivir

COVID-19

Novel over-the-counter Flu and COVID-19 test approved by the FDA

COVID-19

COVID can rebound back…even without Paxlovid!

COVID-19

Four major sub-types of long COVID identified

COVID-19

Management of COVID related ARDS: What have we learnt during the pandemic?

COVID-19

Scientists create new, more potent antibodies to treat coronavirus variants

COVID-19

A new coronavirus variant BQ.1.1 may surge the infection rate

COVID-19

8 in 10 people deal with brain fogging after long COVID

COVID-19

Omicron infected exhale 1000 times more viral RNA than other variants

COVID-19

Never seen before symptoms of Omicron on the rise

Back to top